Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,362 | -108,408 | -78,347 | -52,965 | -24,116 |
| Depreciation Amortization | 2,975 | 11,744 | 7,968 | 5,864 | 2,896 |
| Accounts receivable | 5,291 | -2,284 | 4,409 | 7,712 | 5,415 |
| Accounts payable and accrued liabilities | -1,453 | 2,727 | 2,614 | -829 | 63 |
| Other Working Capital | 727 | -3,257 | 768 | 4,357 | 2,798 |
| Other Operating Activity | -387 | 12,646 | 2,577 | -438 | -2,607 |
| Operating Cash Flow | $-20,209 | $-86,832 | $-60,011 | $-36,299 | $-15,551 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,615 | 68,036 | 46,229 | 12,135 | 5,783 |
| PPE Investments | -2,503 | -9,450 | -6,560 | -3,594 | -802 |
| Investing Cash Flow | $34,112 | $58,586 | $39,669 | $8,541 | $4,981 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,841 | 5,022 | 4,483 | 1,282 | 868 |
| Financing Cash Flow | $1,841 | $5,022 | $4,483 | $1,282 | $868 |
| Beginning Cash Position | 29,766 | 52,990 | 52,990 | 52,990 | 52,990 |
| End Cash Position | 45,510 | 29,766 | 37,131 | 26,514 | 43,288 |
| Net Cash Flow | $15,744 | $-23,224 | $-15,859 | $-26,476 | $-9,702 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,209 | -86,832 | -60,011 | -36,299 | -15,551 |
| Capital Expenditure | -2,503 | -9,450 | -6,560 | -3,594 | -802 |
| Free Cash Flow | -22,712 | -96,282 | -66,571 | -39,893 | -16,353 |